| No. | Drug Name | Active Ingredient | Date | What It’s Used For |
| 23. | Orbactiv | oritavancin | 8/6/2014 | To treat adults with skin infections1 T! z. G! ?: \ s$ e$ L& o2 B2 u8 c4 F
Press Release |
| 22. | | empagliflozin | 8/1/2104 | To improve gylcemic control in adults with type 2 diabetes5 j: b1 b8 |( }" F4 |1 j
Press Release |
| 21. | | olodaterol | 7/31/2014 | To treat chronic obstructive pulmonary disease" h1 B1 g3 y/ p' b9 T9 _4 E
Press Release |
| 20. % G: P( q2 q6 }; M
2 k- R) d/ N# B | | idelalisib | 7/23/2014 | To treat patients with trhee types of blood cancers0 b6 ^ P* Z. _ Z. y
Press Release |
| 19. | Kerydin- P# ~+ t) m: b+ z5 T1 m/ ]8 T
% E9 F$ y, `3 Z- n. g/ G6 e | tavaborole | 7/7/2014 | For the topical treatment of onychomycosis of the toenails
! J7 h& ?8 p6 T! q* ]; G( t (No Press Release) |
| 18. | | belinostat | 7/3/2014 | To treat patients with peripheral T-cell lymphoma (PTCL) + P6 u( a& W# B' f/ c) }3 F
Press Release |
| 17. | | tedizolid phosphate | 6/20/2014 | To treat adults with skin infections
3 B' B, `# t' t+ I/ v' {5 V1 R' j: X Press Release |
| 16. | Jublia6 S- n1 u2 G4 I" N. C3 M' k
' ]7 S. N( P. x: R4 T, m, P, j | efinaconazole | 6/6/2014 | Treat mild to moderate onychomycosis (fungal infection)
! ?& ~! P! M9 m# _* t+ x# H5 P No Press Release |
| 15. | Dalvance
: T1 Y( U9 |# ^" W3 {* a/ s
5 B/ @7 k" b: G( h | dalbavancin | 5/23/2014 | To treat adults with skin infections5 O0 N. A6 t8 t9 c* T. o3 O* @
Press Release |
| 14. | Entyvio
0 N3 n2 N5 l5 `" | 3 C" U3 W. d g) S; D1 {" S
| vedolizumab | 5/20/2014 | To treat adult patients with moderate to severe ulcerative colitis and adult patients with moderate to severe Crohn‘s disease
( d! L, t g5 O' Y0 P# x& s Press Release |
| 13. | Zontivity
2 r$ S! Z% m( ^; Y; H& t # s( G& b+ f: T3 [4 ?, I
| vorapaxar | 5/8/2014 | To reduce the risk of heart attacks and stroke in high-risk patients
D( B t* ]3 ^, @4 U5 X. E Press Release |
| 12. | | ceritinib | 4/29/2014 | To treat patients with a certain type of late-stage (metastatic) non-small cell lung cancer (NSCLC)
/ {$ ]: m( E% M0 g Press Release |
| 11. | | siltuximab | 4/23/2014 | To treat patients with multicentric Castleman’s disease (MCD), a rare disorder similar to lymphoma (cancer of the lymph nodes)( ?' V8 \8 i, {4 v! W; S! K+ g) Z
Press Release |
| 10. | | ramucirumab | 4/21/2014 | To treat patients with advanced stomach cancer or gastroesophageal junction adenocarcinoma- ]$ l# ~9 H: \7 v8 J0 \8 C& U; ^
Press Release |
| 9. | | albiglutide | 4/15/2014 | To improve glycemic control, along with diet and exercise, in adults with type 2 diabetes
% W- \& o- l- ]7 K; W: a Press Release |
| 8. | | apremilast | 3/21/2014 | To treat adults with active psoriatic arthritis (PsA)
+ g( I( N& M9 i1 {% w7 w0 a) O Press Release |
| 7. | | miltefosine | 3/19/2014 | To treat a tropical disease called leishmaniasis' X8 q9 Y4 s: Y# \8 T+ k
Press Release |
| 6. | | florbetaben F 18 injection | 3/19/2014 | For Positron EmissionTomography (PET) imaging of the brain |
| 5. | | metreleptin for injection | 2/24/2014 | To treat the complications of leptin deficiency
% Q" h. q7 x7 U$ G% c Press Release |
| 4. | | droxidopa | 2/18/2014 | To treat neurogenic orthostatic hypotension (NOH) l& W( G9 {7 e+ ~; l$ A5 u9 t, Q9 h
Press Release |
| 3. | | elosulfase alfa | 2/14/2014 | Treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome)+ Z% h. S* n4 G9 o) C5 e
Press Release |
| 2. | | tasimelteon | 1/31/2014 | To treat non-24- hour sleep-wake disorder (“non-24”) in totally blind individuals. Non-24 is a chronic circadian rhythm (body clock) disorder in the blind that causes problems with the timing of sleep.Press Release |
| 1. | | dapaglifozin | 1/8/2014 | To improve glycemic control, along with diet and exercise, in adults with type 2 diabetes
3 j) @9 L; ] F6 `( k% H9 Q Press Release |
|手机版|药群论坛
( 蜀ICP备15007902号 )
收藏
支持
反对